Ledger.Open graph →
SEC Form D · Amendment · filed May 25, 2016

Daktari Diagnostics, Inc

Offering
$22.5M
Sold
$22.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Aaron Sandoski · Cambridge, MADirectorDavid Rubin · Cambridge, MADirectorThierry Bernard · Cambridge, MADirectorJason R. Ferche · St Cloud, MNDirectorDaniel G. Coborn · St Cloud, MNDirectorPeter Kaspar · Cambridge, MADirectorDonald Hawthorne · Cambridge, MAExec · DirectorGregory A. Schumacher · St Cloud, MNDirectorPatrick K. Edeburn · St Cloud, MNDirectorAlvin M. Kern · St Cloud, MNDirectorPeter Kaspar · Cambridge, MADirectorDonald Hawthorne · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗